Stay updated on Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Sign up to get notified when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.

Latest updates to the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page
- Check6 days agoChange DetectedThe record history adds a new revision entry (v3.3.2) and removes the previous revision (v3.3.1).SummaryDifference0.1%

- Check13 days agoChange DetectedFooter shows a revision label updated from v3.2.0 to v3.3.1; there is no change to the study record content, history, or links. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check20 days agoChange DetectedThe government funding notice banner at the top of the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check34 days agoChange DetectedRecord History shows a single version (2022-10-13) with no changes recorded.SummaryDifference0.1%

- Check63 days agoChange Detected- Updated operating-status notice and new version tag (v3.2.0) added; old version tag (v3.1.0) removed. The page now provides current status guidance and a newer software/document version.SummaryDifference13%

- Check70 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0; no other substantive content changes observed.SummaryDifference0.3%

Stay in the know with updates to Belantamab Combo in Lenalidomide Refractory MM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Belantamab Combo in Lenalidomide Refractory MM Clinical Trial page.